Skip to main content
. 2013 Oct 31;13:511. doi: 10.1186/1471-2334-13-511

Table 5.

Combined effect of TLR9 and IFNG SNPs on the development of pulmonary tuberculosis

TLR9 1174 A/G IFNG 2109G/A PTB patients, n (%) LTBI controls n (%) Adjusted OR* (95% CI) p value Adjusted OR & (95% CI) p value PTB patients, n (%) Healthy controls without MTB infection n (%) Adjusted OR* (95% CI) p value Adjusted OR & (95% CI)p value
AA/AG
GG/GA
97 (48.5)
122 (61.9)
Ref.
Ref.
97 (48.5)
103 (52.6)
Ref.
Ref.
AA/AG
AA
62 (31.0)
51 (25.9)
1.54 (0.97-2.43) p = 0.065
1.97 (1.12-3.47) p = 0.019
62 (31.0)
60 (30.6)
1.10 (0.70-1.73) p = 0.683
1.02 (0.59-1.77) p = 0.941
G/G
GG/GA
29 (14.5)
18 (9.1)
2.04 (1.07-3.91) p = 0.031
2.17 (0.96-4.91) p = 0.062
29 (14.5)
20 (10.2)
1.55 (0.82-2.94) p = 0.178
1.41 (0.65-3.08) p = 0.399
G/G
A/A
12 (6.0)
6 (3.1)
2.53 (0.92-7.00) p = 0.073
4.31 (0.21-15.31) p = 0.024
12 (6.0)
13 (6.6)
0.98 (0.43-2.25) p = 0.965
0.95 (0.34-2.62) p = 0.918
p for trend     0.004 0.002     0.433 0.697

Abbreviations: CI confidence interval, LTBI latent M. tuberculosis infection, MTB Mycobacterium tuberculosis, OR odds ratio, PTB pulmonary tuberculosis, SNP single nucleotide polymorphism.

*Partly adjusted for age and gender.

&Fully adjusted for age, gender, education level, income, body mass index, number of BCG vaccination scars and smoking.